New Study Found Red Light at 633nm Reduced Inflammatory Acne by 36% After 8 Weeks of Daily Treatment…Non-Drug Option Gaining Evidence

April 7, 2026

Recent clinical research has generated excitement about red light therapy as a potential non-drug option for inflammatory acne, but the headline claims require important clarification. While light-based phototherapy has demonstrated measurable effectiveness in reducing acne lesions, the reality of the current research is more nuanced than headlines suggest. A 2025 study published in the Journal of Clinical and Aesthetic Dermatology evaluated a combination of blue light (415nm) and red light (633nm) phototherapy in 30 patients, finding that 86% of participants achieved meaningful improvement in acne severity—a result that exceeded expected outcomes by a notable margin. However, this research involved combination therapy rather than red light alone, and the study ran for 7 weeks, not 8 weeks as sometimes reported.

The distinction matters because it affects how you should interpret the evidence if you’re considering light therapy for acne. Red light at 633nm appears to work most effectively when paired with blue light in a complementary approach, not as a standalone treatment. The actual lesion reduction observed—a mean decrease of 13.07 inflammatory lesions from baseline—represents meaningful clinical improvement for participants, but it’s different from the “36% reduction” sometimes cited in popularized summaries. Understanding what the research actually shows is the first step toward making an informed decision about whether light therapy might work for your acne.

What Does Current Clinical Research Show About Red Light and Inflammatory Acne?
Understanding 633nm Red Light and Combination Phototherapy Mechanisms
Clinical Study Results, Success Rates, and What “36%” Actually Means
How Red Light Therapy Works at the Cellular Level
Critical Limitations and Important Practical Considerations
Comparing Red Light Therapy to Other Non-Drug Acne Treatments
The Future of Light-Based Acne Treatment and Emerging Research
Conclusion
Frequently Asked Questions

What Does Current Clinical Research Show About Red Light and Inflammatory Acne?

The clinical evidence for light-based acne treatment has evolved significantly over the past decade. The most recent rigorous study examined a cohort of 30 participants ranging from ages 14 to 45, split equally between male and female subjects, all with diagnosed inflammatory acne. Over a 7-week treatment period using FDA-cleared wearable LED devices designed for home use, participants using the combination 415nm/633nm phototherapy demonstrated consistent improvements. The mean reduction in inflammatory lesion count was 13.07 lesions measured from baseline to week 7, which for someone starting with moderate acne could represent a meaningful improvement in skin clarity. Importantly, this study focused on combination therapy rather than 633nm red light used in isolation.

Why combination therapy? The research suggests that blue light (415nm) and red light (633nm) work through different mechanisms on acne-causing bacteria and skin inflammation. Blue light targets the bacterial component more directly, while red light appears to address underlying inflammation and promote healing. One notable finding from the body of research: studies using alternating blue and red light therapy reported even larger improvements, with some showing 69% lesion reduction at 8 weeks post-treatment. This demonstrates that the wavelengths appear complementary rather than redundant. The takeaway is that if you’re considering light therapy, the most evidence-backed approach involves both wavelengths working together, not red light alone.

What Does Current Clinical Research Show About Red Light and Inflammatory Acne?

Understanding 633nm Red Light and Combination Phototherapy Mechanisms

The 633nm wavelength sits in the red portion of the visible light spectrum and has specific properties that make it theoretically appealing for acne treatment. Red light penetrates deeper into the skin compared to blue light, reaching into the dermal layer where some of the inflammatory processes underlying acne occur. It’s believed to work partly by stimulating mitochondrial energy production in skin cells, potentially enhancing cellular repair mechanisms and reducing the inflammatory cascade that makes acne painful and persistent. However, it’s crucial to understand that the clinical evidence demonstrating these benefits consistently comes from studies using combination therapy—both 415nm blue and 633nm red light—rather than red light monotherapy. This is an important limitation that often gets glossed over in marketing materials and wellness blogs.

Existing clinical studies focused specifically on 633nm red light used alone for acne are sparse or unavailable. The efficacy data we have comes from devices that deliver both wavelengths, making it impossible to isolate the specific contribution of the 633nm component alone. This matters if you’re shopping for light therapy devices—devices claiming results based on red light alone may not have the same level of clinical validation. The research also shows that device specifications matter significantly; the FDA-cleared wearable devices tested in clinical studies were specifically engineered for consistent light delivery over defined treatment areas. Consumer devices vary widely in their specifications, power output, and whether they use the validated wavelength combinations.

Clinical Study Results, Success Rates, and What “36%” Actually Means

The statistic frequently cited as a “36% reduction” in headlines requires clarification. The research actually found that 86% of study participants achieved a 1-grade improvement or greater on the Investigator’s Global Assessment (IGA) scale—a standard dermatological measure of acne severity. This 86% success rate exceeded the predetermined 50% minimum success threshold by 36 percentage points.

In other words, the study was designed with the expectation that at least 50% of participants would improve; the actual result of 86% suggested the treatment worked considerably better than anticipated. This is genuinely promising, but it’s a different claim than saying “acne lesions were reduced by 36%.” To put the actual lesion reduction in perspective: the mean decrease of 13.07 inflammatory lesions over 7 weeks means that a person starting with, say, 25-30 inflammatory spots might expect to see roughly half that number by the end of the treatment period. The consistency across participants was notable—improvements were seen across different age groups (14-45 years) and both sexes, suggesting the treatment wasn’t limited to a specific population subtype. It’s worth noting that these were all patients with clinically significant inflammatory acne who were willing to commit to daily treatment for seven consecutive weeks, so the results may not directly apply to someone with very mild acne or to someone unlikely to adhere to a daily routine.

Clinical Study Results, Success Rates, and What

How Red Light Therapy Works at the Cellular Level

The theoretical mechanism behind red light therapy for acne involves several biological pathways. Red light wavelengths, particularly around 630-700nm, penetrate into the dermis and are absorbed by chromophores in the mitochondrial electron transport chain, specifically by cytochrome c oxidase. This interaction is thought to increase ATP production, the energy currency of cells. For acne-prone skin, this increased cellular energy could support better barrier function, enhanced immune response to acne-causing bacteria, and faster resolution of inflammatory lesions. Additionally, red light has been shown in various studies to reduce pro-inflammatory cytokines, the signaling molecules that drive the redness and swelling characteristic of inflammatory acne.

The combination with blue light adds another layer: blue light (specifically around 415nm) has well-documented bactericidal effects against *Cutibacterium acnes* (formerly *Propionibacterium acnes*), the primary bacteria involved in acne pathogenesis. Blue light generates reactive oxygen species within bacterial cells, effectively killing the organism without requiring antibiotics. When combined, the two wavelengths address acne from multiple angles—reducing bacterial load (blue light) while simultaneously reducing inflammation and supporting skin healing (red light). This is why the research consistently points to combination therapy as more effective than either wavelength alone. Real-world analogy: it’s similar to treating an infection with both an antibiotic (targeting bacteria) and an anti-inflammatory (reducing tissue damage)—the combination addresses the problem more completely than either approach in isolation.

Critical Limitations and Important Practical Considerations

The current body of research, while promising, has several limitations that warrant careful consideration before investing in light therapy devices. Most clinical studies involved small sample sizes—typically 20-30 participants—which means larger, longer-term studies are needed to confirm whether results hold up in broader populations. The 7-week study was rigorous in design but relatively short-term; we have less data on whether improvements persist beyond the treatment period or whether ongoing maintenance therapy is required. Additionally, study participants were typically highly compliant, using their devices daily as directed in a controlled research setting. Real-world adherence to daily light therapy is often lower, which could mean results in typical use may be less impressive than the clinical trial results.

Another practical limitation: light therapy devices are device-dependent, meaning efficacy varies based on the specific device used, its power output, wavelength accuracy, and consistency of delivery. The FDA-cleared devices tested in clinical studies are not the same as every consumer light therapy device available online. Marketing materials often reference the clinical studies while using devices with different specifications, which is somewhat misleading. Cost is also a legitimate consideration—quality devices can range from $100 to $500+, and you’ll need to commit to using the device consistently for at least 7 weeks to assess whether it’s working for your skin. For some people with moderate to severe acne, combining light therapy with other evidence-based treatments (like topical retinoids or, when appropriate, oral medications) might be more effective than light therapy alone.

Critical Limitations and Important Practical Considerations

Comparing Red Light Therapy to Other Non-Drug Acne Treatments

Light-based acne treatment stands alongside several other non-pharmaceutical approaches, each with different levels of clinical support and practical tradeoffs. Topical retinoids (like adapalene, available over-the-counter) have decades of robust research demonstrating their effectiveness for reducing inflammatory and comedonal acne, though they require 8-12 weeks of consistent use and can cause initial skin irritation. Chemical peels and microdermabrasion offer mechanical approaches to clearing clogged pores but are typically less effective for inflammatory acne specifically. Dietary modifications—though often oversold—have modest supporting evidence for some people, particularly regarding high-glycemic foods and dairy. Light therapy occupies a middle ground: it has solid emerging clinical evidence for inflammatory acne specifically, requires daily commitment over weeks, and works without side effects for most people, but it’s relatively newer compared to topical retinoids.

The practical comparison: If you’re considering light therapy, you’re likely choosing between that and topical treatments (retinoids, benzoyl peroxide, salicylic acid). Both require consistent daily use over multiple weeks. Light therapy has fewer side effects (primarily temporary redness or sensitivity in very sensitive skin), while topical retinoids are often more accessible, cheaper, and have longer clinical track records. Some dermatologists suggest combining approaches—light therapy plus topical treatments—might offer additive benefits, though this isn’t yet well-studied. For severe inflammatory acne, oral medications like isotretinoin (Accutane) remain the gold standard, though they carry more significant considerations. The choice should reflect your acne severity, budget, tolerance for potential side effects, and commitment to a daily routine.

The Future of Light-Based Acne Treatment and Emerging Research

The field of phototherapy for acne is evolving, with researchers exploring optimizations that could improve results beyond current findings. Current investigations are examining whether different treatment schedules (varying frequency, duration, or timing of light exposure) might enhance effectiveness. Some preliminary research suggests that pulsed light delivery might be superior to continuous light, though this needs confirmation in clinical studies. There’s also growing interest in whether combining light therapy with topical treatments—particularly with retinoids or other anti-inflammatory agents—could produce better results than light therapy alone, which would align with the combination-therapy thinking that has already proven effective for blue and red light working together.

Another emerging direction involves portable, wearable light therapy devices specifically designed for acne, which could improve real-world adherence compared to fixed devices. As the technology matures and larger, longer-term studies accumulate, we’ll likely gain clearer understanding of which patients benefit most from light therapy, optimal treatment protocols, and whether the improvements observed in 7-week studies persist months or years later. The current evidence already positions light-based therapy as a credible non-drug option for inflammatory acne, particularly for people seeking to avoid medication side effects or those who haven’t responded well to conventional treatments. As more research emerges, light therapy may find its established place in acne management protocols alongside, rather than as a replacement for, other proven treatments.

Conclusion

Red light therapy, particularly when combined with blue light as shown in recent clinical research, demonstrates measurable effectiveness for reducing inflammatory acne. A rigorous 2025 study found that 86% of participants achieved meaningful improvement in acne severity over 7 weeks of daily treatment using combination 415nm/633nm phototherapy, with an average reduction of 13.07 inflammatory lesions. However, the evidence base is most robust for combination therapy rather than red light alone, and results require consistent daily commitment to treatment for at least 7 weeks.

Understanding the nuance of the research—what the studies actually measured, what limitations exist, and how this compares to other treatments—is essential for making an informed decision about whether light therapy makes sense for your acne. If you’re considering light therapy as a non-drug acne option, start with research into FDA-cleared devices validated in clinical studies, budget time for a 7-8 week trial period to assess efficacy, and discuss the approach with a dermatologist if you’re using other acne treatments simultaneously. Light therapy works best when realistic expectations are set: it’s an effective tool for managing inflammatory acne, not a guaranteed cure, and results vary based on individual skin biology, device quality, and treatment adherence. For many people with moderate inflammatory acne, it represents a legitimate evidence-based alternative to medication, particularly for those seeking to minimize systemic effects or topical irritation from conventional treatments.

Frequently Asked Questions

Can red light therapy at 633nm work alone for acne, or does it need to be combined with blue light?

Current clinical evidence comes from combination therapy using both 633nm red and 415nm blue light together. Red light alone at 633nm doesn’t have the same level of clinical validation for acne treatment specifically. The wavelengths appear to work synergistically—blue light targets the bacteria, while red light reduces inflammation—so combination therapy is more effective than either wavelength in isolation.

How long do results last after I stop using the light therapy device?

The clinical research only tracked results during the 7-week treatment period. There’s limited data on whether improvements persist, decline, or require maintenance therapy. Some dermatologists suggest ongoing periodic use may be needed to maintain results, but this isn’t yet firmly established in rigorous research.

Is light therapy safe? Are there side effects?

Light therapy using FDA-cleared acne devices is generally well-tolerated. Possible side effects are minimal and temporary, primarily including mild redness or slight skin sensitivity during the treatment period. It doesn’t cause systemic side effects the way oral acne medications might. However, people with light-sensitive conditions or taking photosensitizing medications should consult a healthcare provider first.

How much improvement should I realistically expect?

Based on the clinical study, expect an average reduction of roughly 13 inflammatory lesions over 7 weeks. The study found that 86% of participants achieved at least one grade of improvement on the acne severity scale. Results vary individually, and some people may see more dramatic improvements while others see more modest changes.

Can I use light therapy if I’m already on topical acne medications?

This isn’t extensively studied, but there’s no clear contraindication. Some dermatologists believe combining approaches might be beneficial. However, certain topical products like strong retinoids or benzoyl peroxide can increase light sensitivity, so discuss the combination with a dermatologist before starting light therapy.

How much do light therapy devices cost, and is this worth the investment?

FDA-cleared acne light therapy devices typically range from $100 to $500+ depending on features and brand. Whether the investment makes sense depends on your acne severity, budget, and whether you’ve already tried and failed other approaches. If you’re not responding to conventional treatments or seeking to avoid medication, it may be worth the cost for a 7-8 week trial. Insurance typically doesn’t cover these devices.